Annual Drug Patent Expirations for PLUVICTO
Pluvicto is a drug marketed by Novartis and is included in one NDA. It is available from one supplier. There are three patents protecting this drug.
This drug has eigthy-nine patent family members in thirty-two countries.
The generic ingredient in PLUVICTO is lutetium lu-177 vipivotide tetraxetan. One supplier is listed for this compound. Additional details are available on the lutetium lu-177 vipivotide tetraxetan profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
